Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4287384
Max Phase: Preclinical
Molecular Formula: C30H54N12O10
Molecular Weight: 742.84
Molecule Type: Small molecule
Associated Items:
ID: ALA4287384
Max Phase: Preclinical
Molecular Formula: C30H54N12O10
Molecular Weight: 742.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(N)=O
Standard InChI: InChI=1S/C30H54N12O10/c1-14(2)22(41-25(48)16(31)6-4-10-36-30(34)35)29(52)42-11-5-7-20(42)28(51)40-19(13-44)27(50)37-15(3)24(47)38-17(8-9-21(32)45)26(49)39-18(12-43)23(33)46/h14-20,22,43-44H,4-13,31H2,1-3H3,(H2,32,45)(H2,33,46)(H,37,50)(H,38,47)(H,39,49)(H,40,51)(H,41,48)(H4,34,35,36)/t15-,16-,17-,18-,19-,20-,22-/m0/s1
Standard InChI Key: SSDFWPVZMQRIJU-LBYOCRPYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 742.84 | Molecular Weight (Monoisotopic): 742.4086 | AlogP: -6.60 | #Rotatable Bonds: 22 |
Polar Surface Area: 380.37 | Molecular Species: BASE | HBA: 12 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.30 | CX Basic pKa: 11.89 | CX LogP: -8.29 | CX LogD: -10.54 |
Aromatic Rings: 0 | Heavy Atoms: 52 | QED Weighted: 0.03 | Np Likeness Score: 0.05 |
1. Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.. (2018) Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids., 9 (5): [PMID:30108977] [10.1039/C8MD00115D] |
Source(1):